Johnson & Johnson doubles down on Ortho breakup plans as a 6% share collapse contrasts with strong pharmaceutical earnings and medical device pressures.
ReadyFlow works equally well in the arm or thigh, with new data supporting consistent drug exposure and diuretic effects.
Emcure Pharmaceuticals moves to simplify its corporate structure as its board approves a draft merger scheme to absorb subsidiaries Emcutix Biopharmaceuticals and Zuventus Healthcare.
It is past 11 pm. Your day's work is done, dinner is over and there is little left to do. Yet the phone is still in your hand. One last email turns into a scroll through social media, followed by a few videos and messages.
Akums unveils a palm-free peptide skincare range targeting winter dryness, skin-barrier support and evolving consumer demand for specialized moisturization.
Granules’ 2,000 crore capex milestone strengthens its peptide CDMO push while accelerating complex generics, oncology, and higher-value pharmaceuticals.
Industry experts and technology specialists explore drug development, regulatory readiness, food processing, rheology and product characterisation at Day One in Navi Mumbai
Anupam Rasayan moves beyond agrochemicals into branded pharma CDMO after acquiring Bliss GVS Pharma for Rs 1,750 crore.
Complex injectables in Indian pharma are gaining importance as companies invest in specialised R&D, complex formulations, and higher-value drug development.
Glenmark adapalene 0.1 percent launch in the US highlights an established acne therapy and its relevance to India's evolving dermatology treatment landscape.
.jpg)
, CDSCO.jpg)
